Ion Chromatography System (Toxic Elements - Cr Speciation)

The Food and Drug Administration is forecasting the acquisition of an ion chromatography system to support the development and validation of a high-performance liquid chromatography coupled with inductively coupled plasma mass spectrometry method for speciation of chromium in food matrices, dietary supplements, and bottled water. This system is specifically intended to separate and quantify the toxicologically distinct chromium species, Cr(III) and Cr(VI), with greater resolution and precision than conventional liquid chromatography techniques, ensuring accurate risk assessment and regulatory compliance. The method will enhance the agency’s capacity to monitor chromium exposure through consumable products and inform public health decisions. The procurement is classified under NAICS code 541990 for other scientific and technical consulting services and is posted as a forecast opportunity without a specified set-aside type. The point of contact for program inquiries is the Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the contracting officer role remains TBD. The system will be deployed under FDA’s existing operational framework, with no specific place of performance listed beyond the agency’s jurisdiction, and no set-aside provisions are indicated for small business or other socioeconomic categories.